First certified service provider appointed for Agilent target enrichment and microarrays
Agilent Technologies has announced that Beckman Coulter Genomics has achieved Certified Service Provider status for the company's target enrichment system
Agilent Technologies has announced that Beckman Coulter Genomics has achieved Certified Service Provider (CSP) status for the Agilent SureSelect Target Enrichment System, including new SureSelect XT that combines sequencing library preparation and gDNA preparative reagents. Through its acquisition of Cogenics, Beckman Coulter is also a CSP for Agilent SurePrint microarrays, making the company the first CSP for both Agilent platforms.
“We’re very pleased to see Beckman Coulter Genomics leverage their considerable expertise in next-gen sequencing and genomic analysis with the performance of the Agilent SureSelect and SurePrint platforms,” said Chris Grimley, PhD, Agilent marketing director, Genomics. “Life science and pharmaceutical researchers around the world will reap the benefits of this powerful association.”
Beckman is now certified to perform SureSelect target enrichment upstream of both the AB SOLiD and Illumina genome analyser sequencers. SureSelect has been reported to increase the speed and cost efficiency of next-generation sequencing workflows by enabling experiments to focus on genomic regions of interest rather than sequencing the entire genome.
For more information visit the companies’ websites at www.agilent.com and www.beckmangenomics.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
